Epidemiology of Chinese Herb Nephropathy and Its Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Kidney Diseases
Both
Kidney Diseases
Trial Information
Epidemiology of Chinese Herb Nephropathy and Its Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism
Inclusion Criteria:
- Patient with suspected Chinese herb nephropathy, and their family Control group match
for sex age and geographic area (with or without herabla use)
Type of Study:
Observational
Study Design:
Time Perspective: Cross-Sectional
Principal Investigator
Kwan-Dun Wu, MD, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
National Taiwan University Hospital
Authority:
Taiwan: Department of Health
Study ID:
9461701139
NCT ID:
NCT01503645
Start Date:
May 2006
Completion Date:
Related Keywords:
- Kidney Diseases
- kidney diseases
- drugs, Chinese herbal
- aristolochic acid
- polymorphism, genetic
- Kidney Diseases
Name | Location |
|---|
